Proteonomix, Inc. (PROT) Settles Litigation
4/1/2013 10:07:41 AM
More...
|
Proteonomix, Inc. (PROT) Announces Extension of Deadline
1/14/2013 10:18:26 AM
More...
|
Proteonomix, Inc. (PROT) to Require Physical Exchange of Certificates
1/11/2013 8:29:45 AM
More...
|
Proteonomix, Inc. (PROT) Announces Restructuring
1/8/2013 10:19:33 AM
More...
|
Proteonomix, Inc. (PROT) Updates Status of UMK-121 Testing
1/8/2013 10:18:30 AM
More...
|
Proteonomix, Inc. (PROT) Announces Screening of Patients With End Stage Liver Disease in Its Clinical Study of UMK-121
11/20/2012 9:25:28 AM
More...
|
Proteonomix, Inc. (PROT) Announces Finalizing ECRF for Its Clinical Trial of UMK 121 in Patients With End Stage Liver Disease
10/26/2012 10:45:25 AM
More...
|
Proteonomix, Inc. (PROT) Announces Its Clinical Trial of UMK-121 in Patients With End Stage Liver Disease Has Been Listed on ClinicalTrials.gov
10/23/2012 12:20:33 PM
More...
|
Proteonomix, Inc. (PROT) Announces IRB Approval for Its Clinical Trial of UMK-121 in Patients With End Stage Liver Disease
10/4/2012 11:23:37 AM
More...
|
Proteonomix, Inc. (PROT) Announces Agreement With the University of Medicine and Dentistry of New Jersey to Conduct a Phase 1 Trial With UMK-121 in End-Stage Liver Disease
9/14/2012 9:00:48 AM
More...
|
|